Structure-activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer's disease.

MLA

Wu, Chengyao, et al. “Structure-Activity Relationship, in Vitro and in Vivo Evaluation of Novel Dienyl Sulphonyl Fluorides as Selective BuChE Inhibitors for the Treatment of Alzheimer’s Disease.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 36, no. 1, Dec. 2021, pp. 1860–73. EBSCOhost, https://doi.org/10.1080/14756366.2021.1959571.

APA

Wu, C., Zhang, G., Zhang, Z.-W., Jiang, X., Zhang, Z., Li, H., Qin, H.-L., & Tang, W. (2021). Structure-activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 1860–1873. https://doi.org/10.1080/14756366.2021.1959571

Chicago

Wu, Chengyao, Guijuan Zhang, Zai-Wei Zhang, Xia Jiang, Ziwen Zhang, Huanhuan Li, Hua-Li Qin, and Wenjian Tang. 2021. “Structure-Activity Relationship, in Vitro and in Vivo Evaluation of Novel Dienyl Sulphonyl Fluorides as Selective BuChE Inhibitors for the Treatment of Alzheimer’s Disease.” Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1): 1860–73. doi:10.1080/14756366.2021.1959571.